Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, November 11 at 2:00 PM ET

Register Free →

DIETARY SUPPLEMENT, THERAPEUTIC

Awarded
SPE2DP-26-Q-0125Federal

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

AI Contract Overview

Show more

The contract specifies the procurement of an unflavored therapeutic dietary supplement in powder form, with each package containing six individual packets, each yielding 8 to 10 ounces of liquid when reconstituted. The product is lactose-free and must have a shelf life of 18 months, with no more than three months elapsed between manufacture and delivery to the government. Each package must be sealed in a unit container that protects the contents from damage and packed in commercial shipping containers suitable for safe transport at the lowest cost to the delivery point. All packaging and labeling must comply with Medical Marking Standard No. 1, superseding MIL-STD-129, and must adhere to DLA’s Master List of Technical and Quality Requirements, which take precedence over ASTM D3951. Palatalization must follow DLA Packaging Requirements for Procurement. The unit of issue is the package, with four packages required, delivered in two separate shipments to two distinct government addresses—one in Perry Point, Maryland, and another in San Antonio, Texas—by traceable freight means only, prohibiting parcel post. Delivery is required within 35 days after order date, with inspection and acceptance occurring at the destination. Pricing is firm fixed, with no variance allowed in quantity. The supplier must comply with federal clauses related to veteran employment reports, sustainable products, and wide area workflow payment. The item’s NSN is 8940-01-317-9838, and the solicitation number is SPE2DP-26-Q-0125.

General Info

Unflavored powder supplement, 80g packets, 6 per package, 18-month shelf life, delivered in 35 days via traceable freight to two locations.

Contract Value

$520

NAICS

325411 - Medicinal and Botanical Manufacturing

Place of Performance

MD, USA

Set-Aside

NONE

Award Issued Date

Documents

2

RFQ SPE2DP-26-Q-0125 for Dietary Supplement

PDF, High priority: read this first9 pages · rfq
High

SPE2DP-26-P-1183 - Order for Supplies or Services

PDF, High priority: read this firstaward
High

AI Contract Breakdown

Uniform Contract Format

Sign up to view the full breakdown with detailed analysis of each section.

Timeline

1 update
PhaseAwarded
Posted

Solicitation

Notice updated

The notice description changed.

Awarded

Contract was awarded

Ready to pursue this opportunity?

Get full access to track this contract, build proposals with AI assistance, and manage your pipeline.

Organization & Contact Information

Show more
AgencyDepartment Of Defense → Defense Logistics Agency
Contacts1 person available
OfficeUSA
Office AddressUSA

Full Description

Show more
DLA award SPE2DP26P1183 posted on DIBBS. Awardee: SZY HOLDINGS, LLC (CAGE 0AG09) Total Contract Price: $520.00 Award Date: 09-16-2026 Solicitation: SPE2DP-26-Q-0125 Line items: - DIETARY SUPPLEMENT, THERAPEUTIC (NSN/Part 8940013179838, PR 7013937344) - DIETARY SUPPLEMENT, THERAPEUTIC (NSN/Part 8940013179838, PR 7013732121)

Similar Contracts

Same NAICS industry code

NAICS: 325411
Federal
NOI - B2B Award entitled - Developing Red Cell-Sp
Solicitation # 75N98027Q00017
Solicitation 75N98027Q00017 is a combined synopsis and notice of intent for a non-competitive award by the National Institutes of Health (NIH) to Purdue University, specifically the Purdue Institute for Drug Discovery. The contract supports the Bench-to-Bedside study Developing Red Cell-Specific Spleen Tyrosine Kinase (SYK) Inhibitors for Treating Sickle Cell Disease. The scope of work for the Year 1 requirement involves the synthesis, scale-up, characterization, and optimization of lead SYK inhibitors S1115 and S1213, with a delivery requirement of approximately 3 to 5 grams of each compound along with supporting analytical and potency data. The award is justified as non-competitive because Purdue University possesses the project-specific knowledge and prior research experience necessary to avoid technical risk and duplication of effort. The acquisition is conducted under FAR 12.603 for commercial items and is not expected to exceed the simplified acquisition threshold. Research activities will be performed at Purdue University in West Lafayette, Indiana, with deliverables sent to the National Heart, Lung, and Blood Institute in Bethesda, Maryland. The associated NAICS code is 325411 for Medicinal and Botanical Manufacturing, and the requirement is not set aside for small businesses. Administrative requirements include active registration in the System for Award Management and the use of the Invoicing Processing Platform for three-way match payments. Responses were due by November 4, 2026, to the contracting specialist, Nicholas Capobianco.
National Institutes Of Health Olao

POSTED

9 days ago

DEADLINE

in 6 days
View Details

More opportunities from Department Of Defense → Defense Logistics Agency

Same awarding agency

Ready to Pursue This Opportunity?

Get AI-powered intelligence on this solicitation and the ones like it

Every page of the solicitation package shredded into a compliance breakdown

AI-powered matching based on your capabilities and past performance

Competitor and incumbent history on the requirement

Automated alerts on amendments, Q&A deadlines, and award

Miguel
Hillary
Keith Deutsch
Christine

Join 750+ contractors already using CLEATUS